{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-113764","form_type":"8-K","ticker":"LXEO","cik":"0001907108","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2024-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.323743+00:00","generated_at":"2026-05-30T17:30:23.576264+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lexeo updates LX2020 cohort data timeline to late Q1/early Q2 2025; LX1001 data at CTAD Oct 2024","bullets":["Expects to share Cohort 1 data from LX2020 for PKP2-ACM in late Q1 or early Q2 2025.","Plans to present LX1001 data for APOE4-associated Alzheimer's at CTAD conference in Oct 2024.","Corporate presentation posted on website; used for investor meetings going forward.","No changes to financial guidance or capital structure disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-113764","json":"https://secwatch.observer/filing/0000950170-24-113764.json","markdown":"https://secwatch.observer/filing/0000950170-24-113764.md","text":"https://secwatch.observer/filing/0000950170-24-113764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000095017024113764/0000950170-24-113764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000095017024113764/lxeo-20241009.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:30:23.576264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}